Use of mineralocorticoid receptor antagonist in ST elevation myocardial infarction

J Nucl Cardiol. 2022 Oct;29(5):2336-2339. doi: 10.1007/s12350-021-02801-9. Epub 2021 Sep 13.

Authors

Muhammad H Khan¹, Myron C Gerson^{2

3}

Affiliations

¹ University of Cincinnati Department of Internal Medicine, Cincinnati, USA.
² University of Cincinnati Department of Cardiovascular Medicine, Cincinnati, USA. gersonml@ucmail.uc.edu.
³ Division of Cardiovascular Health and Disease, Department of Internal Medicine, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH, 45267, USA. gersonml@ucmail.uc.edu.

PMID: 34519013
DOI: 10.1007/s12350-021-02801-9

No abstract available

Publication types

Editorial
Comment

MeSH terms

Heart Failure*
Humans
Mineralocorticoid Receptor Antagonists / therapeutic use
Myocardial Infarction* / diagnostic imaging
ST Elevation Myocardial Infarction* / diagnostic imaging

Substances

Mineralocorticoid Receptor Antagonists